GlassScriptPhysician profile
Maranda D Gurkin
NPI 1477292209
$1,836.56
in general payments reported to CMS, 2019-2025
24 companies · $50.20 in 2025
The $50.20 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $147 · 2023: $1,032 · 2024: $608 · 2025: $50.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $457.76 | 2022-2024 | Trelegy Ellipta, Arexvy, Nucala |
| Astrazeneca Pharmaceuticals LP | $192.47 | 2022-2024 | Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.65 | 2022-2024 | Ofev, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $132.04 | 2022-2024 | Opsumit, Uptravi |
| Inspire Medical Systems, INC. | $120.03 | 2023-2024 | Inspire |
| United Therapeutics Corporation | $111.25 | 2023-2025 | Tyvaso, Tyvaso |
| Amgen INC. | $73.40 | 2023-2024 | Tezspire |
| Insmed, INC. | $65.22 | 2023-2024 | Arikayce |
| Tactile Systems Technology INC | $62.14 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Mylan Specialty L.P. | $55.67 | 2023-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $50.31 | 2023-2024 | Glassia |
| Merck Sharp & Dohme LLC | $47.93 | 2023-2024 | Zerbaxa |
| Pfizer INC. | $46.16 | 2023-2024 | |
| Harmony Biosciences LLC | $41.07 | 2022-2023 | Wakix |
| Genzyme Corporation | $34.35 | 2023-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $27.86 | 2023 | Sunosi |
| Regeneron Healthcare Solutions, INC. | $26.94 | 2024 | Dupixent |
| Grifols USA, LLC | $24.64 | 2024 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $20.27 | 2023 | Acthar |
| Baxter Healthcare | $18.80 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Ani Pharmaceuticals, INC. | $15.86 | 2024 | Purified Cortrophin Gel |
| Electromed, INC. | $14.21 | 2023 | Smartvest |
| Hikma Pharmaceuticals USA | $13.63 | 2023 | Ryaltris |
| Philips North America LLC | $12.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maranda Gurkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.